Both in Pharmaceuticals
Oric Pharmaceuticals vs Kura Oncology
Over the past year ORIC returned −27.2% and KURA returned +5.0%; their daily moves had a correlation of 0.21.
ORIC −27.2% KURA +5.0%Growth of $1, one year, split-adjusted
| Metric | ORIC | KURA |
|---|---|---|
| Price | $9.24 | $10.26 |
| Market cap | $957.8M | $912.7M |
| Today | +2.78% | −2.84% |
| 1 month | −26.2% | −3.7% |
| 6 months | −5.4% | +17.0% |
| Year to date | +13.0% | −1.3% |
| 1 year | −28.5% | 0.0% |
| Revenue growth (YoY) | — | +36.5% |
| Gross margin | — | 98.8% |
| Net margin | — | −327.3% |
| P/E (TTM) | — | — |
| Price / sales | — | 11.8× |
| Net cash | $264.8M | $509.2M |
| Dividend yield | — | — |
| Volatility (60d) | 93.5% | 55.5% |
| Short % of float | 25.5% | 18.3% |
| Next earnings | — | — |
Shading marks the stronger figure where one clearly exists (lower is better for valuation and volatility).